Who invested in En Carta Diagnostics?
En Carta Diagnostics, a DeepTech startup from France, raised €5 million in a funding round announced on 10 July 2026. Investors: Blue Forest Ventures (lead), ring-capital, 50 Partners Health, Bpifrance and CentraleSupélec.
En Carta Diagnostics
€5 millionDeepTechBlue Forest Venturesleadring-capital50 Partners HealthBpifranceCentraleSupélec
Franceeu-startups.com
Questions founders ask
- Who invested in En Carta Diagnostics?
- Blue Forest Ventures, ring-capital, 50 Partners Health, Bpifrance and CentraleSupélec invested in En Carta Diagnostics's funding round, announced on 10 July 2026 (source: eu-startups.com).
- Who led En Carta Diagnostics's funding round?
- Blue Forest Ventures, according to eu-startups.com.
- How much did En Carta Diagnostics raise?
- €5 million in its funding round, as reported by eu-startups.com.
Raising next? See which investors fit your round.
In 30 minutes you'll know which funds matter for your round.
Request accessRounds are read from public funding coverage and matched against our investor database. Every line links to the article it came from — that article, not this page, is the source. Amounts are quoted exactly as the article stated them; we do not convert currencies. Individual angel investors named in an article are not listed here.
Something wrong? Tell us what to correct and we will fix it. To be removed from Oka entirely, use /remove-me.